Stratum Biosciences secures $2M seed round for AI-powered skin biology discovery
27 March 2026 — Stratum Biosciences has closed a $2 million seed round, with participation from Harvard Business School Alumni Angels of Greater New York and Skin Angels, to scale its AI-powered skin-biology discovery platform and expand R&D partnerships. CEO and co-founder Dr Ross Pearlman: “As a dermatologist, I see every day that the biggest gap in skin innovation is our limited understanding of skin biology.”
Albion Trinity Capital is an investor in Stratum Biosciences.